Contribution of Explicit Solvent Effects to the Binding Affinity of Small-Molecule Inhibitors in Blood Coagulation Factor Serine Proteases

被引:106
作者
Abel, Robert [1 ]
Salam, Noeris K. [1 ]
Shelley, John [1 ]
Farid, Ramy [1 ]
Friesner, Richard A. [2 ,3 ]
Sherman, Woody [1 ]
机构
[1] Schrodinger, New York, NY 10036 USA
[2] Columbia Univ, Dept Chem, New York, NY 10027 USA
[3] Columbia Univ, Ctr Biomol Simulat, New York, NY 10027 USA
关键词
factor VIIa; factor Xa; serine proteases; thrombin; WaterMap; FACTOR-XA INHIBITORS; RAY CRYSTAL-STRUCTURE; NONCOVALENT THROMBIN INHIBITORS; PRO-ARG CHLOROMETHYLKETONE; PROTEIN-LIGAND BINDING; HUMAN ALPHA-THROMBIN; ACTIVE-SITE; 2-CARBOXYINDOLE SCAFFOLD; VIIA INHIBITORS; PI INTERACTIONS;
D O I
10.1002/cmdc.201000533
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The prevention of blood coagulation is important in treating thromboembolic disorders, and several serine proteases involved in the coagulation cascade have been classified as pharmaceutically relevant. Whereas structure-based drug design has contributed to the development of some serine protease inhibitors, traditional computational methods have not been able to fully describe structure-activity relationships (SAR). Here, we study the SAR for a number of serine proteases by using a method that calculates the thermodynamic properties (enthalpy and entropy) of the water that solvates the active site. We show that the displacement of water from specific subpockets (such as S1-4 and the ester binding pocket) of the active site by the ligand can govern potency, especially for cases in which small chemical changes (i.e., a methyl group or halogen) result in a substantial increase in potency. Furthermore, we describe how relative binding free energies can be estimated by combining the water displacement energy with complementary terms from an implicit solvent molecular mechanics description binding.
引用
收藏
页码:1049 / 1066
页数:18
相关论文
共 51 条
  • [41] Factor VIIa inhibitors: Target hopping in the serine protease family using X-ray structure determination
    Shiraishi, Takuya
    Kadono, Shojiro
    Haramura, Masayuki
    Kodama, Hirofumi
    Ono, Yoshiyuki
    Iikura, Hitoshi
    Esaki, Tohru
    Koga, Takaki
    Hattori, Kunihiro
    Watanabe, Yoshiaki
    Sakamoto, Akihisa
    Yoshihashi, Kazutaka
    Kitazawa, Takehisa
    Esaki, Keiko
    Ohta, Masateru
    Sato, Haruhiko
    Kozono, Toshiro
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (16) : 4533 - 4537
  • [42] Neutral inhibitors of the serine protease factor Xa
    Shrader, WD
    Young, WB
    Sprengeler, PA
    Sangalang, JC
    Elrod, K
    Carr, G
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1801 - 1804
  • [43] SITKOFF D, 2008, 236 ACS NAT M DIV ME
  • [44] Progress in the development of synthetic thrombin inhibitors as new orally active anticoagulants
    Steinmetzer, T
    Stürzebecher, J
    [J]. CURRENT MEDICINAL CHEMISTRY, 2004, 11 (17) : 2297 - 2321
  • [45] Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site
    Tucker, TJ
    Lumma, WC
    Mulichak, AM
    Chen, ZG
    NaylorOlsen, AM
    Lewis, SD
    Lucas, R
    Freidinger, RM
    Kuo, LC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) : 830 - 832
  • [46] Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position
    Tucker, TJ
    Brady, SF
    Lumma, WC
    Lewis, SD
    Gardell, SJ
    Naylor-Olsen, AM
    Yan, YW
    Sisko, JT
    Stauffer, KJ
    Lucas, BJ
    Lynch, JJ
    Cook, JJ
    Stranieri, MT
    Holahan, MA
    Lyle, EA
    Baskin, EP
    Chen, IW
    Dancheck, KB
    Krueger, JA
    Cooper, CM
    Vacca, JP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (17) : 3210 - 3219
  • [47] Discovery and evaluation of potent P1 aryl heterocycle-based thrombin inhibitors
    Young, MB
    Barrow, JC
    Glass, KL
    Lundell, GF
    Newton, CL
    Pellicore, JM
    Rittle, KE
    Selnick, HG
    Stauffer, KJ
    Vacca, JP
    Williams, PD
    Bohn, D
    Clayton, FC
    Cook, JJ
    Krueger, JA
    Kuo, LC
    Lewis, SD
    Lucas, BJ
    McMasters, DR
    Miller-Stein, C
    Pietrak, BL
    Wallace, AA
    White, RB
    Wong, B
    Yan, YW
    Nantermet, PG
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (12) : 2995 - 3008
  • [48] Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding
    Young, Tom
    Abel, Robert
    Kim, Byungchan
    Berne, Bruce J.
    Friesner, Richard A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (03) : 808 - 813
  • [49] Structure of a serine protease poised to resynthesize a peptide bond
    Zakharova, Elena
    Horvath, Martin P.
    Goldenberg, David P.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (27) : 11034 - 11039
  • [50] Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors
    Zbinden, KG
    Obst-Sander, U
    Hilpert, K
    Kühne, H
    Banner, DW
    Böhm, HJ
    Stahl, M
    Ackermann, J
    Alig, L
    Weber, L
    Wessel, HP
    Riederer, MA
    Tschopp, TB
    Lavé, T
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (23) : 5344 - 5352